SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

HUL gains on getting Chandigarh NCLT’s nod for merger deal with GSK Consumer Healthcare

27 Feb 2020 Evaluate

Hindustan Unilever is currently trading at Rs. 2258.05, up by 17.10 points or 0.76% from its previous closing of Rs. 2240.95 on the BSE.

The scrip opened at Rs. 2245.00 and has touched a high and low of Rs. 2259.55 and Rs. 2200.70 respectively. So far 53713 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2307.20 on 19-Feb-2020 and a 52 week low of Rs. 1649.70 on 05-Apr-2019.

Last one week high and low of the scrip stood at Rs. 2279.00 and Rs. 2200.70 respectively. The current market cap of the company is Rs. 487082.71 crore.

The promoters holding in the company stood at 67.18%, while Institutions and Non-Institutions held 19.00% and 13.82% respectively.

Hindustan Unilever (HUL) has received an approval from the Chandigarh bench of National Company Law Tribunal (NCLT) for the scheme of amalgamation for the merger of the company and GlaxoSmithKline Consumer Healthcare (GSK Consumer Healthcare).

Earlier, the Mumbai Bench of the NCLT had sanctioned the scheme on November 6, 2019 and the order was subject to sanction of the Chandigarh Bench of NCLT. The effective date of the scheme will be communicated upon being finalised in accordance with the procedure specified by the Mumbai NCLT and Chandigarh NCLT.

HUL is India’s largest Fast Moving Consumer Goods Company with a heritage of over 80 years in India and touches the lives of nine out of ten Indian households.

Hindustan Unilever Share Price

2241.10 101.65 (4.75%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2241.10
Godrej Consumer Prod 1108.20
Dabur India 442.10
Colgate Palmol. (I) 2106.20
P&G Hygiene 10006.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×